Universal Biosensors Inc (UBI) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
1 CORPORATE AVENUE VICTORIA, 3178 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 25,978 | 15,318 | 23,562 | 30,230 | 11,798 | 26,260 | |||
| Cash and cash equivalents | 25,978 | 15,318 | 23,562 | 30,230 | 11,798 | 26,260 | |||
| Restricted cash and investments | 527 | 1,969 | 2,175 | 2,055 | 16 | ||||
| Receivables | 974 | 476 | 73 | 117 | 50,210 | 4,397 | |||
| Inventory, net of allowances, customer advances and progress billings | 3,142 | 2,144 | 1,880 | 1,078 | 744 | 662 | |||
| Inventory | 3,142 | 2,144 | 1,880 | 1,078 | 744 | 662 | |||
| Prepaid expense | 490 | 399 | 108 | 136 | 158 | 887 | |||
| Other current assets | 825 | 4,544 | 3,599 | 3,457 | 1,105 | 876 | |||
| Other undisclosed current assets | 4,736 | ||||||||
| Total current assets: | 36,672 | 24,850 | 31,396 | 37,073 | 64,031 | 33,082 | |||
| Noncurrent Assets | |||||||||
| Finance lease, right-of-use asset, after accumulated amortization | 58 | ✕ | ✕ | ||||||
| Operating lease, right-of-use asset | 4,422 | ✕ | ✕ | ||||||
| Property, plant and equipment | 4,583 | 4,100 | 4,355 | 4,750 | 5,626 | 9,960 | |||
| Intangible assets, net (including goodwill) | 11,015 | 12,651 | 14,287 | 15,928 | |||||
| Intangible assets, net (excluding goodwill) | 11,015 | 12,651 | 14,287 | 15,928 | |||||
| Restricted cash and investments | 320 | 812 | 2,319 | 4,908 | 320 | ||||
| Other noncurrent assets | 89 | 38 | 3,220 | ||||||
| Other undisclosed noncurrent assets | (11,015) | 2,050 | 4,025 | ||||||
| Total noncurrent assets: | 9,473 | 19,652 | 24,986 | 25,586 | 5,946 | 13,180 | |||
| TOTAL ASSETS: | 46,145 | 44,502 | 56,382 | 62,659 | 69,978 | 46,262 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 6,156 | 3,908 | 2,202 | 2,413 | 7,942 | 3,352 | |||
| Taxes payable | ✕ | ✕ | 4,353 | ||||||
| Employee-related liabilities | ✕ | ✕ | 670 | 603 | 782 | 1,197 | 1,550 | ||
| Accounts payable | 268 | 437 | 448 | 615 | 695 | 330 | |||
| Accrued liabilities | 5,888 | 2,801 | 1,152 | 1,015 | 1,697 | 1,473 | |||
| Deferred revenue | 30 | 38 | 1,628 | 2,682 | ✕ | ✕ | |||
| Debt | 75 | 65 | |||||||
| Business combination, contingent consideration, liability | 2,214 | 2,067 | 1,500 | 2,141 | |||||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 2,357 | ||
| Other liabilities | 3,024 | 2,823 | 2,660 | 2,924 | 2,903 | 2,626 | |||
| Other undisclosed current liabilities | 1,587 | 500 | 972 | 2,357 | |||||
| Total current liabilities: | 13,086 | 9,402 | 8,963 | 10,161 | 13,201 | 8,335 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 56 | 1,691 | 3,635 | 14,843 | |||||
| Long-term debt, excluding current maturities | 41 | 14,843 | |||||||
| Finance lease, liability | 56 | ✕ | ✕ | ||||||
| Liabilities, other than long-term debt | 6,864 | 5,772 | 5,786 | 7,073 | 2,600 | 6,064 | |||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 3,464 | ||
| Deferred revenue | 1,422 | ✕ | ✕ | ||||||
| Asset retirement obligations | 2,921 | 2,721 | 2,735 | 2,600 | 2,600 | 2,600 | |||
| Deferred income tax liabilities | 3,051 | 3,051 | 3,051 | ✕ | ✕ | ||||
| Operating lease, liability | 3,944 | 1,691 | 3,595 | ✕ | ✕ | ||||
| Other undisclosed noncurrent liabilities | 48 | 29 | 21 | 32 | 3,503 | 4,251 | |||
| Total noncurrent liabilities: | 6,968 | 7,492 | 9,442 | 7,105 | 6,103 | 25,157 | |||
| Total liabilities: | 20,054 | 16,894 | 18,404 | 17,265 | 19,304 | 33,493 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 26,091 | 27,608 | 37,977 | 45,394 | 50,674 | 12,769 | |||
| Common stock | 21 | 18 | 18 | 18 | 18 | 18 | |||
| Additional paid in capital | 119,041 | 93,738 | 93,570 | 93,397 | 93,815 | 93,451 | |||
| Accumulated other comprehensive loss | (292) | (323) | (293) | (342) | (326) | (302) | |||
| Accumulated deficit | (65,824) | (55,317) | (47,679) | (42,833) | (80,397) | (79,633) | |||
| Other undisclosed equity, attributable to parent | (26,855) | (10,507) | (7,638) | (4,846) | 37,564 | (765) | |||
| Total equity: | 26,091 | 27,608 | 37,977 | 45,394 | 50,674 | 12,769 | |||
| TOTAL LIABILITIES AND EQUITY: | 46,145 | 44,502 | 56,382 | 62,659 | 69,978 | 46,262 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 9,358 | 5,778 | 3,203 | 6,897 | 69,948 | 25,486 | ||
| Revenue, net | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 25,191 | |
| Other income | 2 | 112 | 3 | |||||
| Cost of revenue (Cost of Goods and Services Sold) | (2,386) | (3,672) | (2,580) | (3,572) | (2,511) | (3,951) | ||
| Other undisclosed gross profit | (4,833) | (491) | (295) | |||||
| Gross profit: | 2,139 | 2,106 | 623 | 3,326 | 66,945 | 21,240 | ||
| Operating expenses | (37,033) | (17,144) | (13,181) | (13,725) | (20,523) | (20,224) | ||
| Operating income (loss): | (34,894) | (15,038) | (12,558) | (10,400) | 46,423 | 1,016 | ||
| Nonoperating income (expense) | 4,988 | 4,531 | 4,920 | 4,236 | (4,506) | (1,781) | ||
| Investment income, nonoperating | 382 | 50 | 294 | 826 | 491 | 172 | ||
| Other nonoperating income (expense) | 182 | 431 | 2,123 | 57 | (3) | |||
| Interest and debt expense | (155) | (2,991) | (10) | |||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (29,905) | (10,507) | (7,793) | (6,164) | 38,926 | (774) | ||
| Other undisclosed income from continuing operations before income taxes | 155 | 2,991 | 10 | |||||
| Income (loss) from continuing operations before income taxes: | (29,905) | (10,507) | (7,638) | (6,164) | 41,917 | (765) | ||
| Income tax expense (benefit) | 3,051 | 1,317 | (4,353) | |||||
| Income (loss) from continuing operations: | (26,855) | (10,507) | (7,638) | (4,846) | 37,564 | (765) | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | (10,507) | (7,638) | (4,846) | 37,564 | (765) | |
| Net income (loss) available to common stockholders, diluted: | (26,855) | (10,507) | (7,638) | (4,846) | 37,564 | (765) | ||
Comprehensive Income ($ in thousands)
| 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (26,855) | (10,507) | (7,638) | (4,846) | 37,564 | (765) | ||
| Other comprehensive income (loss) | 32 | (30) | 49 | (16) | (24) | (4) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (26,823) | (10,537) | (7,589) | (4,862) | 37,540 | (768) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.